eli lilly retatrutide press release 2024 2025 Scientific Diabetes Disclosures retatrutide phase 2 results 2024

In the REDEFINE 1 clinical trial, patients treated with the combination achieved a mean weight loss of 22.7% at 68 weeks, and more than 40% of participants achieved at least a 25% reduction in body weight

Participants were randomised to a target dose at baseline, and anyone discontinuing during escalation is still counted in the arm they were randomised to

(Da Silva Guimares et al

Practical Tips If Your Provider Says Occasional Alcohol Is Okay If your healthcare provider says occasional alcohol is reasonable for you, use caution

Add-ins like almond butter or whole almonds increase calories, but they also provide essential nutrients and can help you feel fuller longer